Earlier intervention for cancer
The government’s call for evidence to inform the forthcoming National Cancer Plan highlights that earlier diagnosis will be one of the major themes. However, despite the consensus that early intervention is necessary, actual progress has been limited. This report, commissioned by AstraZeneca, explores the reasons behind this lack of progress. The report’s recommendations include a call for renewed political leadership and accountability, for cross-party support for action to provide continuity, for the redesign of funding flows to support earlier intervention, for shifting the focus to reducing late diagnosis, and for the use of technology to make earlier intervention possible.